On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on ...

BioNTech (BNTX) and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of novel ...

Today, BioNTech revealed a definitive agreement to acquire China-based Biotheus, a clinical-stage biotechnology company ...

Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational PD-L1 x VEGF-A bispecific antibody, with potential to ...

CHICAGO--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T ...

GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Signa Magnus MRI scanner.

Exercise can be beneficial for men with prostate cancer - as well as helping prevent it - but there are also three to avoid ...

Procedures like partial nephrectomy for kidney cancer, endoscopic resection or partial cystectomy for bladder cancer, and ...

Researchers at Tel Aviv University (TAU) can add to that list their important discovery of a cancer mechanism that has been ...

The system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions. The company noted ...

It's still a couple of years away from achieving actual profitability, but it's taking steps in the right direction. Finally, ...

The Biospecimen contract research services market is segmented into the biospecimen types and therapeutics areas. Based on the type of biospecimen types, the market is segmented into oncological and ...